LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway
2024 · Journal of Experimental & Clinical Cancer Research · 17 citations
https://doi.org/10.1186/s13046-024-03110-y
H
Huiwen Luan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
50
Citations
3
h-index
3
i10-index
Huiwen Luan is an academic researcher from Shandong University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lymphoma Diagnosis and Treatment & Immune Cell Function and Interaction. The author has an h-index of 3, co-authored 47 publications.
ORCID: 0009-0005-7144-4682Papers by this author
worksIGSF9 promotes tumor invasion and metastasis through GSK-3β/β-catenin mediated EMT in lung cancer
2024 · Neoplasia · 14 citations
https://doi.org/10.1016/j.neo.2024.101067
LILRB4 specific overexpression in myeloid cells promotes tumor progression and immunosuppression in mouse models
2025 · Biochemical and Biophysical Research Communications · 1 citations
https://doi.org/10.1016/j.bbrc.2025.151536
Figure S8 from Targeting the immunoglobulin IGSF9 enhances anti-tumor T cell activity and sensitivity to anti-PD-1 immunotherapy
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27028771.v1
Supplementary Data from Targeting the immunoglobulin IGSF9 enhances anti-tumor T cell activity and sensitivity to anti-PD-1 immunotherapy
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27028768.v1
Figure S7 from Targeting the immunoglobulin IGSF9 enhances anti-tumor T cell activity and sensitivity to anti-PD-1 immunotherapy
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27028774.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat